Jianzeng Zhang

Statistics

Publications

Citations

684

H-Index

Active since

2020

Affiliations

Chinese PLA General Hospital(Current)

Cell Technology (China)

Shanghai Changzheng Hospital

Hubei University of Technology

Jianzeng Zhang is an author at Chinese PLA General Hospital specializing in mesenchymal stromal cell clinical trials, cell therapy safety assessment, and joint disease.

ORCID

Publications per year

2020–2025

Publications

Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2

Yuhuan Xu, Jinghui Dong, Weimin An et al. · Journal of Infection · 2020 · 546 citations · Full text

Medicine, Infectious Diseases, Radiology +15

Lactate-upregulated NADPH-dependent NOX4 expression via HCAR1/PI3K pathway contributes to ROS-induced osteoarthritis chondrocyte damage

Yifan Huang, Guan Wang, Lu Ding et al. · Redox Biology · 2023 · 94 citations · Full text

Dentistry, Molecular Medicine, Pathobiology +17

Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial

Tiantian Li, Bo Zhang, Hui Fang et al. · EBioMedicine · 2023 · 34 citations · Full text

Pharmacy, Translational Sciences, Cell Therapy +14

Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial

Mengqi Yuan, Le Song, Ze-Rui Wang et al. · Stem Cell Research & Therapy · 2025 · 10 citations · Full text

Pharmacy, Internal Medicine, Cell Therapy +14

1–4 of 4